Silver Book Fact

Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.

Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. NEJM. 2005; 353(17): 84-92. http://www.nejm.org/doi/full/10.1056/NEJMoa050518

Reference

Title
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Publication
NEJM
Publication Date
2005
Authors
Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al.
Volume & Issue
Volume 353, Issue 17
Pages
84-92
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.  
  • Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.  
  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.  
  • New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer  
  • For women age 40 or older, timely mammograms could reduce breast cancer mortality by about 16%–compared to those who are not screened.